| Serial Number | 97593502 |
| Word Mark | SLOREL |
| Filing Date | Thursday, September 15, 2022 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, November 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Surgical implants comprised of living tissues for guided tissue regeneration; implants comprising living tissue; implantable materials for use in guided tissue regeneration in the nature of implants comprising living tissue; Surgical implants comprised of living tissues used in transplants, namely, vascular grafts being living tissue and human allograft tissue; surgical implants comprised of living tissues; human allograft tissue; bone void fillers comprised of living tissues; Stem cells for medical purposes, namely, surgical implants grown from stem cells; pharmaceutical preparations for use in tissue transplantation; tissue-regenerative pharmaceutical preparations; medicines for human purposes, namely, pharmaceutical preparations for the treatment of musculo-skeletal disorders; medicines for human purposes, namely, a drug delivery system comprising liquids, powders, tablets or capsules for the continuous release of a wide variety of therapeutic agents, namely, pharmaceutical preparations for the treatment of musculo-skeletal disorders; drugs for medical purposes, namely, drugs for use in bioregenerative procedures, drugs for use for regenerative purpose, drugs for use to assist with artificial bone growth, drugs for use in accelerating bone formation, drugs for use to stimulate new bone formation; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the prevention of diseases of the musculo- skeletal system; pharmaceutical preparations for the treatment of Musculo-skeletal disorders; cellular function activating agents for medical purposes; pharmaceutical preparations for use in organ transplantation; biological tissue cultures for medical purposes; drug delivery agents in the form of liquid, powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films added to bone substitutes; drug delivery agents in the form of dissolvable films for use in bioregenerative procedures; drug delivery agents in the form of dissolvable films that provide sustained release of drugs for use with implants and bone substitutes; drug delivery agents in the form of drug delivery compounds that facilitate sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films with controlled timing and rate of drug release; medicines for human use, namely pharmaceutical preparations for the treatment of musculo-skeletal disorders featuring controlled timing and rate of release; medical bone graft substitute, namely, biological tissue bone grafts; medical bone graft materials, namely, bone fillers consisting of living materials; medical bone graft materials with drug release function being bone growth media consisting of biological materials for medical bone graft purposes with drug release function; medical bone graft materials, namely, biological bone tissue intended for subsequent implantation in a bone graft with drug release function, that provide sustained release of drugs for use with implants and bone substitutes; medical bone graft materials being biological bone tissue intended for subsequent implantation with drug release function that are sold filled with pharmaceutical preparations used with implants and bone substitutes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, October 1, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CG Bio Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Gyeonggi-do 13211 KR |
| Event Date | Event Description |
| Friday, April 14, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, September 19, 2022 | NEW APPLICATION ENTERED |
| Saturday, October 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 14, 2023 | ASSIGNED TO EXAMINER |
| Friday, April 14, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, April 14, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 16, 2023 | LETTER OF SUSPENSION E-MAILED |
| Friday, June 16, 2023 | SUSPENSION LETTER WRITTEN |
| Friday, June 16, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 17, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, August 13, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, November 6, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 6, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 12, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, November 5, 2024 | ASSIGNED TO LIE |
| Wednesday, November 6, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, November 6, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, November 6, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Wednesday, November 6, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, November 6, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, November 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |